Medically reviewed by Jurairat J. Molina, MD Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria ...

Opens in a new tab or window If you're being treated for hives, your physician will want to hear what you think about your treatment. Is it working? Are your symptoms improving, staying the same ...

Looking for reliable medications to treat 'Hives'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications. For informed ...

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore ...

The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.

In November 2021, however, she came up against a case nearly impossible to solve. It all started when Elisha woke up with an ...

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

Hives and rashes are two skin conditions that can look fairly similar. Here, experts explain the difference between hives and a rash, plus treatments.